Mr Alastair Dent FRSC
Managing Director of Fleet Bioprocessing Ltd., a Hampshire-based company specialising in conjugation chemistry for diagnostic and biopharmaceutical applications.
Professor John Hunt CChem MRSC
John’s research focuses on developing breakthrough therapies, devices and technology to repair, replace, augment and in the future regenerate diseased, infected and damaged tissues in humans and other mammals using material interventions. Understanding the generic science to deliver interventional medical therapies requiring the use of a material (living cells are also considered to be a material). These will come from an in depth generic first principles approach to understanding and directing the patient’s cellular and molecular mechanisms and responses related to the clinical outcome and efficacy of medical devices, biocompatibility, inflammation and stem cell biology. Tissue engineering processes are developed and applied, addressing the key areas of patient treatments requiring intervention and material implantation; the materials of choice being researched today also include cells and within that, expertise and intellectual property has been created relating to primary cell sourcing, controlling cell function and phenotype through defining and controlling extracellular matrix interactions, angiogenesis, inflammation and tissue regeneration.
From a strong long lived generic research platform, specific applications and knowledge has been applied to and continue to be developed for musculoskeletal tissues specifically cartilage and bone, visceral and vascular tissues. Professor Hunt’s research has been funded by the European Commission, BBSRC, MRC and EPSRC as well as by Industry. Ph.D in 1992 and D.Sc. in 2006.
He is a Fellow of the Royal Society of Chemistry, a Fellow of the International College of Fellows for Biomaterials Science and Engineering and elected committee member and the treasurer of the society. He is an honorary clinical academic consultant at the Liverpool Heart and Chest NHS trust hospital and an honorary Professor at University of Liverpool. He is a full time Professor and research Theme Leader at Nottingham Trent University; leading the theme Medical Technologies and Advanced Materials. He is on the International editorial board member for the journal Biomaterials and the Biomaterials and Nanotechnology section editor in the International journal of Artificial Organs.
Mr Ken Fantom MRSC
Ken Fantom, (Secretary) Senior Investigator in Biomolecular Analysis section at GlaxoSmithKline. Our research utilises state-of-the-art mass spectrometry in protein analysis and proteomics to investigate the identity, quantity and molecular composition of proteins as well as of cellular metabolites.
Dr Andrew Kenyon
CEO of BioClone Ltd., a London based consultancy company specialising in biopharmaceutical project management, analytical process validation and regulatory guidance. Our areas of interest range from early R&D through to manufacture and pharmacovigilance.
Dr Henry Day MRSC
Analytical Chemist in the consumables product development team at Illumina in Cambridge. For my undergraduate degree I studied Natural Sciences at St. Catharine’s College Cambridge where I specialised in Organic Chemistry. My interest in analytical chemistry developed during my PhD in the School of Pharmacy, University of East Anglia where I was investigating small molecule interactions with alternative DNA secondary structures. During this time my eyes were opened to a wealth of analytical techniques for investigating DNA structure and DNA-ligand interactions.
After completing my PhD I stayed with the analytical sciences in industry working for LGC group in the sport and specialised analytical sciences team. Here I gained a great deal of experience of LC-MS carrying out method development and validation for the analysis of small molecules in biological matrices. Now in my current role I have moved back to the field of Nucleic Acids where my real passion lies and I am applying my expertise in HPLC, LC-MS and other Biophysical and Analytical methods to Illumina’s world-renowned sequencing technology.
Dr Nikola Chmel MRSC
Senior Teaching Fellow in the Department of Chemistry at the University of Warwick. My research interests include development of new methods in polarised light spectroscopy for applications in biochemistry. I am also responsible for the transferrable skills training programme for the Faculties of Science and Medicine at the University of Warwick.
Dr Lynn Dennany MRSC
Lecturer at University of Strathclyde. My research interests focus on the application of analytical detection techniques for chemical and biochemical sensor development. I am particularly interested in the creation of novel materials that have tuneable electronic or photonic properties. These materials can be utilised for new applications in a variety of areas ranging from biomedical devices to forensic applications.
Lynn Dennany Website
Find out more about Dr Dennany's research interests and projects
External links will open in a new browser window
Dr Stefanie Frank
Lecturer in Synthetic Biology at the Department of Biochemical Engineering at UCL. My work is focused on the engineering of microbial metabolic pathways and the spatial organisation of enzymes for biotechnology applications. This involves the use of various analytical techniques for the elucidation of protein structure-function relationships and metabolite detection.
Dr Kirsty High MRSC
Knowledge Exchange Fellow in Analytical Chemistry at the University of York. I am interested in the application of analytical chemistry to the study of organic archaeological materials, in particular understanding how they deteriorate in the burial environment. I spend a lot of time working with archaeologists and heritage management professionals to develop ways of understanding how human impacts on the environment cause damage to archaeology. The chemical analysis of biopolymers, and correlating changes to the altering the geochemistry of the burial environment play a key role in this.
Dr Viv Lindo
Dr Viv Lindo Associate Director, Product Characterisation, MedImmune.After a PhD in Protein Biochemistry at Kings College London (1991-1994), I spent 4yrs as a post Doctoral Researcher at Imperial College London in the Physical Biochemistry group. I moved on to work at SGS M-Scan (formerly M-Scan) with principal involvement in mass spectrometric structural characterisation of molecules to ICH guidelines. I joined MedImmune in January 2011 to head the Product Characterisation team within Analytical Biochemistry.
Dr Frankie Rawson MRSC
Frankie is currently an independent Senior Research Fellow based in the Laboratory of Biophysics and Surface Analysis within the School of Pharmacy at the University of Nottingham. His research interests span the boundary of chemistry and biology and a key area is to develop and nano-electrochemical systems for studying biological electron transfer processes. Thereby, providing new insights into the biological role that redox chemistry plays in modulating cell function. One exciting application of such technology is in the newly coined field of “electroceutics”. Future progress in this field requires both simultaneous sensing and electrical actuation of cell behaviour and is in part what his group are striving towards.
Dr Mark Seymour CChem FRSC
Syngenta Fellow in Analytical Sciences at Syngenta’s Jealott’s Hill International Research Centre. After completing his PhD in Analytical Chemistry, Mark spent 2 years carrying out analytical development work in the pharmaceutical industry. He then moved into chemical manufacturing spending 8 years as a QC manager before joining the agrochemical industry where he has held various positions. Mark now leads Syngenta's global measurement science network.